Moreno-Morillo Francisco Javier, Fernández-Vigo José Ignacio, Burgos-Blasco Barbara, Moriche-Carretero Manuel, López-Guajardo Lorenzo, Donate-López Juan
Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain.
Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain; Centro Internacional de Oftalmología Avanzada, Madrid, Spain.
Photodiagnosis Photodyn Ther. 2022 Sep;39:102953. doi: 10.1016/j.pdpdt.2022.102953. Epub 2022 Jun 9.
To assess the efficacy of an additional photodynamic therapy (PDT) in chronic central serous chorioretinopathy (cCSCR) patients who have two or more previous failed PDTs.
Ten eyes of 10 patients with cCSCR who had received two or more PDTs without complete resolution of the subretinal fluid (SRF) or with early recurrence (before 3 months) were included. An additional half-fluence PDT was performed. Swept-source optical coherence tomography (OCT) and OCT angiography were performed before, 3 days, 1 month, 3 months, 6 months and 12 months after treatment. Age, gender, best-corrected visual acuity (BCVA), subfoveal choroidal thickness, SRF and vessel occlusion in the choriocapillaris (CC) were collected.
The median number of previous PDTs was 3 (range 2 to 4). BCVA before and 12 months after treatment was 72 letters (50 to 95) and 78 letters (55 to 100) (p=0.094). Median initial SRF was 94 µm (50 to 306), being 0 µm (range 0 to 81) at the end of the follow-up (p=0.007). After the additional PDT, 8 out of 10 patients had a complete SRF resorption. All the patients except one who had a complete response (7/8) had an occlusion in the CC 3 days after PDT.
Despite previous failed PDTs in cCSCR, good anatomical results can be achieved, this being more likely if an early vessel occlusion in the CC is observed. Even when the BCVA did not improve, the high rate of fluid resolution could justify the additional PDT treatment in order to maintain visual function.
评估额外光动力疗法(PDT)对既往接受过两次或更多次PDT治疗但未成功的慢性中心性浆液性脉络膜视网膜病变(cCSCR)患者的疗效。
纳入10例cCSCR患者的10只眼,这些患者接受过两次或更多次PDT治疗,但视网膜下液(SRF)未完全消退或早期复发(3个月前)。进行了一次额外的半剂量PDT治疗。在治疗前、治疗后3天、1个月、3个月、6个月和12个月进行扫频源光学相干断层扫描(OCT)和OCT血管造影。收集患者的年龄、性别、最佳矫正视力(BCVA)、黄斑中心下脉络膜厚度、SRF以及脉络膜毛细血管(CC)中的血管阻塞情况。
既往PDT治疗的中位数为3次(范围2至4次)。治疗前和治疗后12个月的BCVA分别为72个字母(50至95)和78个字母(55至100)(p = 0.094)。初始SRF的中位数为94 µm(50至306),随访结束时为0 µm(范围0至81)(p = 0.007)。额外PDT治疗后,10例患者中有8例SRF完全吸收。除1例完全缓解的患者外(7/8),所有患者在PDT治疗后3天CC均出现阻塞。
尽管cCSCR患者既往接受PDT治疗失败,但仍可取得良好的解剖学效果,如果观察到CC早期血管阻塞,则更有可能实现。即使BCVA没有改善,高比例的液体消退也可为额外的PDT治疗提供依据,以维持视觉功能。